Pfizer Inc. announced its plans to invest over $1.26 billion to upgrade its Dublin manufacturing site, Mike McDermott, the company's chief global supply officer, said on Thursday.
The move will enable the pharmaceutical maker to double the production capacity for key substances used in biological drugs. Pfizer last month posted better-than-expected earnings in the third quarter of 2022, as its net income reached $8.6 billion 6% higher compared to the same period in 2021.
━━━━━━━━━━━━━━━
ıllıllı ʟօɮɛʟʟօ ıllıllı #health
The move will enable the pharmaceutical maker to double the production capacity for key substances used in biological drugs. Pfizer last month posted better-than-expected earnings in the third quarter of 2022, as its net income reached $8.6 billion 6% higher compared to the same period in 2021.
━━━━━━━━━━━━━━━
ıllıllı ʟօɮɛʟʟօ ıllıllı #health
Pfizer Inc. announced its plans to invest over $1.26 billion to upgrade its Dublin manufacturing site, Mike McDermott, the company's chief global supply officer, said on Thursday.
💉
The move will enable the pharmaceutical maker to double the production capacity for key substances used in biological drugs. Pfizer last month posted better-than-expected earnings in the third quarter of 2022, as its net income reached $8.6 billion 🤑 6% higher compared to the same period in 2021.
━━━━━━━━━━━━━━━
ıllıllı ʟօɮɛʟʟօ ıllıllı #health
0 Comentários
0 Compartilhamentos
49 Visualizações
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek